Mohamed Addani, Lindsay Beaman, Goldie Smith Byrd, Anthony Atala, Zubin Master
{"title":"Toward equitable regenerative medicine: a health equity research framework for emerging regenerative treatments.","authors":"Mohamed Addani, Lindsay Beaman, Goldie Smith Byrd, Anthony Atala, Zubin Master","doi":"10.1080/17460751.2025.2521963","DOIUrl":null,"url":null,"abstract":"<p><p>Regenerative medicine continues to advance rapidly, yet research examining health disparities within this field remains notably limited. The distinctive characteristics of regenerative therapies - complex manufacturing, specialized delivery, and personalized approaches - present unique challenges for equitable health care access beyond traditional disparities. This gap is concerning as many conditions targeted by regenerative treatments disproportionately affect underserved populations. Our analysis of the literature identifies knowledge gaps and demonstrates the critical need for a multi-level approach to health equity research in regenerative medicine. We propose a research framework involving three key steps. First: systematic investigation of field-specific access barriers through established health disparity frameworks, focusing on factors uniquely relevant to regenerative therapies across individual, interpersonal, organizational, community, and societal levels. Second: development and rigorous evaluation of targeted, multi-level interventions addressing these barriers. Third: implementation of evidence-based strategies using equity-focused frameworks to translate findings into practice, ensuring equity considerations are embedded throughout development and delivery processes. By prioritizing health equity research while many regenerative treatments are still developing, the field has an unprecedented opportunity to create inclusive access pathways and ensure its potentially revolutionary therapies benefits all populations.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":" ","pages":"243-256"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12269665/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regenerative medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1080/17460751.2025.2521963","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
Abstract
Regenerative medicine continues to advance rapidly, yet research examining health disparities within this field remains notably limited. The distinctive characteristics of regenerative therapies - complex manufacturing, specialized delivery, and personalized approaches - present unique challenges for equitable health care access beyond traditional disparities. This gap is concerning as many conditions targeted by regenerative treatments disproportionately affect underserved populations. Our analysis of the literature identifies knowledge gaps and demonstrates the critical need for a multi-level approach to health equity research in regenerative medicine. We propose a research framework involving three key steps. First: systematic investigation of field-specific access barriers through established health disparity frameworks, focusing on factors uniquely relevant to regenerative therapies across individual, interpersonal, organizational, community, and societal levels. Second: development and rigorous evaluation of targeted, multi-level interventions addressing these barriers. Third: implementation of evidence-based strategies using equity-focused frameworks to translate findings into practice, ensuring equity considerations are embedded throughout development and delivery processes. By prioritizing health equity research while many regenerative treatments are still developing, the field has an unprecedented opportunity to create inclusive access pathways and ensure its potentially revolutionary therapies benefits all populations.
期刊介绍:
Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.
Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.
Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.